Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy.

Lorenzen J, Lovric S, Krämer R, Haller H, Haubitz M.

Ann Rheum Dis. 2010 Jun;69(6):1169-71. doi: 10.1136/ard.2009.113621. Epub 2010 Apr 27.

PMID:
20424002
2.

Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis.

Kümpers P, Horn R, Brabant G, Woywodt A, Schiffer M, Haller H, Haubitz M.

Rheumatology (Oxford). 2008 Apr;47(4):484-7. doi: 10.1093/rheumatology/ken023. Epub 2008 Feb 16.

PMID:
18281689
3.

Diagnostic role of endothelial microparticles in vasculitis.

Erdbruegger U, Grossheim M, Hertel B, Wyss K, Kirsch T, Woywodt A, Haller H, Haubitz M.

Rheumatology (Oxford). 2008 Dec;47(12):1820-5. doi: 10.1093/rheumatology/ken373. Epub 2008 Oct 16.

PMID:
18927191
4.

Association of circulating level of high mobility group box 1 with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.

Wang C, Gou SJ, Chang DY, Yu F, Zhao MH, Chen M.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1828-34. doi: 10.1002/acr.22187.

5.
6.

Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.

Hasegawa M, Nishii C, Ohashi A, Tomita M, Nakai S, Murakami K, Nabeshima K, Fujita Y, Ishii J, Hiki Y, Sugiyama S.

Nephron Clin Pract. 2009;113(3):c222-33. doi: 10.1159/000235242. Epub 2009 Aug 18.

PMID:
19690440
7.

Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.

Chen M, Wang F, Zhao MH.

Rheumatology (Oxford). 2009 Apr;48(4):355-8. doi: 10.1093/rheumatology/ken500. Epub 2009 Jan 30.

PMID:
19181656
8.

Intracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with a higher relapse rate in the long-term follow-up.

Hruskova Z, Rihova Z, Mareckova H, Jancova E, Rysava R, Zavada J, Merta M, Löster T, Tesar V.

Arch Med Res. 2009 May;40(4):276-84. doi: 10.1016/j.arcmed.2009.04.001.

PMID:
19608017
9.

Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis.

Haubitz M, Schulzeck P, Schellong S, Schulze M, Koch KM, Brunkhorst R.

Arthritis Rheum. 1997 Sep;40(9):1680-4.

PMID:
9324023
10.

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

Jayne DR, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D, Lockwood CM.

QJM. 2000 Jul;93(7):433-9.

PMID:
10874052
11.

Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.

Brijker F, Magee CC, Tervaert JW, O'Neill S, Walshe JJ.

Clin Nephrol. 1999 Dec;52(6):344-51.

PMID:
10604641
12.

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis.

Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, Jayne D, Harper L; European Vasculitis Study (EUVAS) Group.

Ann Rheum Dis. 2010 Jun;69(6):1036-43. doi: 10.1136/ard.2009.109389. Epub 2009 Jul 1.

PMID:
19574233
13.

Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.

Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH.

Rheumatology (Oxford). 2008 Oct;47(10):1515-20. doi: 10.1093/rheumatology/ken321. Epub 2008 Aug 1.

PMID:
18676500
14.

Modification and validation of the Birmingham Vasculitis Activity Score (version 3).

Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA.

Ann Rheum Dis. 2009 Dec;68(12):1827-32. doi: 10.1136/ard.2008.101279. Epub 2008 Dec 3.

PMID:
19054820
15.

Rapid decrease of anti-beta-glucan antibody as an indicator for early diagnosis of carinii pneumonitis and deep mycotic infections following immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis.

Yoshida M, Ishibashi K, Hida S, Yoshikawa N, Nakabayashi I, Akashi M, Watanabe T, Tomiyasu T, Ohno N.

Clin Rheumatol. 2009 May;28(5):565-71. doi: 10.1007/s10067-009-1096-0. Epub 2009 Feb 4.

PMID:
19190977
16.

Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.

Lovric S, Erdbruegger U, Kümpers P, Woywodt A, Koenecke C, Wedemeyer H, Haller H, Haubitz M.

Nephrol Dial Transplant. 2009 Jan;24(1):179-85. doi: 10.1093/ndt/gfn430. Epub 2008 Aug 6.

PMID:
18685144
17.

Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis.

Abdulahad WH, Kallenberg CG, Limburg PC, Stegeman CA.

Arthritis Rheum. 2009 Sep;60(9):2830-8. doi: 10.1002/art.24747.

18.

The future of ANCA-associated vasculitis.

Holle JU, Wieczorek S, Gross WL.

Rheum Dis Clin North Am. 2010 Aug;36(3):609-21. doi: 10.1016/j.rdc.2010.05.007.

PMID:
20688253
19.

Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe).

Morishita K, Li SC, Muscal E, Spalding S, Guzman J, Uribe A, Abramson L, Baszis K, Benseler S, Bowyer S, Campillo S, Chira P, Hersh AO, Higgins G, Eberhard A, Ede K, Imundo L, Jung L, Kim S, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Lovell DJ, Mason T, McCurdy D, Nanda K, Nassi L, O'Neil KM, Rabinovich E, Ramsey SE, Reiff A, Rosenkranz M, Schikler K, Stevens A, Wahezi D, Cabral DA; ARChiVe Investigators Network.

J Rheumatol. 2012 May;39(5):1088-94. doi: 10.3899/jrheum.111030. Epub 2012 Feb 15.

PMID:
22337238

Supplemental Content

Support Center